Skip to main content

Table 2 Sensitivity and specificity of the DBMA-Fv in relation to chart review at T2

From: Validation of the disease burden morbidity assessment by self-report in a French-speaking population

Disease TP + FN* TP Sensitivity % CI 95%* TN + FP* TN Specificity % CI 95% Prevalence % (n) †
Hypertension 26 20 77.0 56.4 - 91.0 57 55 96.5 87.9 - 99.6 31.3 (83)
Elevated cholesterol 32 26 81.2 63.6 - 92.8 52 50 96.2 86.8 - 99.5 38.1 (84)
Asthma 10 9 90.0 55.5 - 99.7 74 71 95.9 88.6 - 99.2 11.9 (84)
Diabetes 12 9 75.0 42.8 - 94.5 72 71 98.6 92.5 - 100 14.3 (84)
Osteoarthritis 21 14 66.7 43.0 - 85.4 63 55 87.3 76.5 - 94.4 25.0 (84)
Rheumatic disease, other 22 15 68.2 45.1 - 86.1 62 56 90.3 80.1 - 96.4 26.2 (84)
Overweight 16 12 75.0 47.6 - 92.7 67 52 77.6 65.8 - 86.9 19.3 (83)
Angina/coronary artery disease 16 10 62.5 35.4 - 84.8 67 65 97.0 89.6 - 99.6 19.3 (83)
Depression/Anxiety 13 9 69.2 38.6 - 90.9 71 64 90.1 80.7 - 95.9 15.5 (84)
  1. * TP = True Positive; FN = False Negative; TN = True Negative; FP = False Positive; CI 95% = 95% Confidence Interval.
  2. † Total n = 84 (one chart could not be retrieved). Differences between the total n and the actual n used in calculations in some diseases are due to incomplete data in the questionnaires that were not considered in the calculation.